Overall HOTH gets a fundamental rating of 2 out of 10. We evaluated HOTH against 191 industry peers in the Pharmaceuticals industry. While HOTH seems to be doing ok healthwise, there are quite some concerns on its profitability. HOTH is valued expensive and it does not seem to be growing.

Quickly go to:

1. Profitability

2. Health

3. Growth

4. Valuation

5. Dividend

1. Profitability

1.1 Basic Checks

In the past year HOTH has reported negative net income.
In the past year HOTH has reported a negative cash flow from operations.
HOTH had negative earnings in each of the past 5 years.
HOTH had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

Looking at the Return On Assets, with a value of -131.58%, HOTH is doing worse than 83.77% of the companies in the same industry.
Looking at the Return On Equity, with a value of -147.77%, HOTH is doing worse than 70.68% of the companies in the same industry.

		Industry Rank	Sector Rank
ROA	-131.58%
ROE	-147.77%
ROIC	N/A

ROA(3y)-118.92%

ROA(5y)-124.88%

ROE(3y)-143.37%

ROE(5y)-145.96%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

HOTH does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

Compared to 1 year ago, HOTH has more shares outstanding
Compared to 5 years ago, HOTH has more shares outstanding
There is no outstanding debt for HOTH. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

Based on the Altman-Z score of -5.77, we must say that HOTH is in the distress zone and has some risk of bankruptcy.
HOTH's Altman-Z score of -5.77 is on the low side compared to the rest of the industry. HOTH is outperformed by 64.40% of its industry peers.
HOTH has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Altman-Z	-5.77

ROIC/WACCN/A

WACCN/A

2.3 Liquidity

A Current Ratio of 8.81 indicates that HOTH has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 8.81, HOTH is in the better half of the industry, outperforming 76.44% of the companies in the same industry.
A Quick Ratio of 8.81 indicates that HOTH has no problem at all paying its short term obligations.
HOTH has a Quick ratio of 8.81. This is in the better half of the industry: HOTH outperforms 76.96% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	8.81
Quick Ratio	8.81

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 20.30% over the past year.

EPS 1Y (TTM)20.3%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%3.23%

Revenue 1Y (TTM)N/A

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, HOTH will show a quite strong growth in Earnings Per Share. The EPS will grow by 13.53% on average per year.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next Y60.12%

EPS Next 2Y24.4%

EPS Next 3Y13.53%

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

HOTH reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year HOTH is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.